gne8 rgp120/hiv-1
Vaccineexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00000879)
Timeline
Indications
Mechanism of action
- GP41Immunity, active
HIV1 ENV immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gne8 rgp120/hiv-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00007332 | Phase 2 | Dec 16, 2000 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00000879 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT00002402 | Phase 1 | Nov 2, 1999 | VaxGen |
| NCT00002441 | Phase 3 | Nov 2, 1999 | VaxGen |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 1999 |
| VaxGen | For profit | 2 | 2 | 2 | 1999 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 1999 |
3 organizations
Page 1 / 1